Fiasp injection 100 units/mL, manufactured by Novo Nordisk Pharma, is a rapid-acting insulin analog containing Insulin aspart (recombinant) to improve glycemic control in adults and pediatric patients with diabetes mellitus. It is available as 100 units per 1mL vial (YJ code: 2492415A5026) and can be administered with a syringe or an insulin pump.
Fiasp injection 100 units/mL
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →